Financial Statements · From SEC 10-K & 10-Q XBRL Filings
Colgate-Palmolive Co. Revenue & Financial Statements
Colgate-Palmolive Co. reported revenue of $20.4B for the fiscal year ended December 31, 2025, up 1.4% year over year, with net income of $2.3B and diluted EPS of $2.63.
- Company
- Colgate-Palmolive Co. CL · NYSE
- Latest fiscal year
- FY ended Dec 31, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 17.4B | 18.0B | 19.5B | 20.1B | 20.4B |
| Cost of revenue | 7.0B | 7.7B | 8.1B | 7.9B | 8.1B |
| Gross profit | 10.4B | 10.2B | 11.3B | 12.2B | 12.3B |
| Operating income | 3.3B | 2.9B | 4.0B | 4.3B | 3.3B |
| Pretax income | 1.8B | 1.5B | 2.7B | 2.9B | 1.6B |
| Net income | 2.1B | 2.1B | 2.4B | 2.6B | 2.3B |
| Diluted EPS | 2.55 | 2.13 | 2.77 | 3.51 | 2.63 |
| EBITDA | 3.9B | 3.4B | 4.6B | 4.9B | 3.9B |
Quarterly
| USD | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.1B | 5.1B | 5.0B | 4.9B | 4.9B | 5.1B | 5.1B | 5.2B |
| Cost of revenue | 2.0B | 2.0B | 2.0B | 2.0B | 1.9B | 2.0B | 2.1B | 2.1B |
| Gross profit | 3.0B | 3.1B | 3.1B | 3.0B | 3.0B | 3.1B | 3.0B | 3.1B |
| Operating income | 1.0B | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B | 92.0M |
| Pretax income | 967.0M | 1.0B | 986.0M | 993.0M | 953.0M | 1.0B | 992.0M | 108.0M |
| Net income | 601.0M | 622.0M | 792.0M | 591.0M | 795.0M | 936.0M | 771.0M | (5.0M) |
| Diluted EPS | 0.83 | 0.89 | 0.90 | 0.90 | 0.85 | 0.91 | 0.91 | -0.04 |
| EBITDA | 1.2B | — | 1.2B | 1.2B | 1.2B | 1.2B | 1.2B | 265.0M |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 15.0B | 15.7B | 16.4B | 16.0B | 16.3B |
| Current assets | 4.4B | 5.1B | 5.3B | 5.3B | 5.7B |
| Cash & equivalents | 832.0M | 775.0M | 966.0M | 1.1B | 1.3B |
| Total liabilities | 14.1B | 14.9B | 15.4B | 15.5B | 16.0B |
| Current liabilities | 4.1B | 4.0B | 4.7B | 5.8B | 6.9B |
| Long-term debt | 7.2B | 8.7B | 8.2B | 7.3B | 6.9B |
| Total debt | 7.2B | 8.8B | 8.2B | 7.9B | 8.0B |
| Stockholders’ equity | 609.0M | 401.0M | 609.0M | 212.0M | 54.0M |
| Net debt | 6.4B | 8.0B | 7.3B | 6.8B | 6.7B |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | 3.3B | 2.6B | 3.7B | 4.1B | 4.2B |
| Investing cash flow | (592.0M) | (1.6B) | (742.0M) | (534.0M) | (817.0M) |
| Financing cash flow | (2.8B) | (952.0M) | (2.8B) | (3.4B) | (3.3B) |
| Capital expenditure | 567.0M | 696.0M | — | — | — |
| Free cash flow | 2.8B | 1.9B | — | — | — |
| Dividends paid | — | — | — | — | — |
| Stock-based compensation | 135.0M | 125.0M | 122.0M | 135.0M | 155.0M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every CL filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.